| LP145992-6 | Cholesterol in pericardial fluid | COMPONENT | |
| LP145993-4 | Creatinine in pleural fluid | COMPONENT | |
| LP145994-2 | Creatinine in serum | DIVISORS | |
| LP145995-9 | Protein in pericardial fluid | COMPONENT | |
| LP145996-7 | Creatinine in peritoneal fluid | COMPONENT | |
| LP145997-5 | Protein in peritoneal fluid | COMPONENT | |
| LP145998-3 | Cholesterol in pleural fluid | COMPONENT | |
| LP145999-1 | Triglyceride in pleural fluid | COMPONENT | |
| LP14600-8 | Transfuse blood exchange transfusion | COMPONENT | 1 |
| LP14601-6 | Transfuse blood product other | COMPONENT | 1 |
| LP14602-4 | Transfuse cryoprecipitate | COMPONENT | 1 |
| LP146026-2 | Pyruvate dehydrogenase IgG | COMPONENT | 1 |
| LP146027-0 | Sjogrens syndrome-A extractable nuclear 52kD IgG | COMPONENT | 4 |
| LP146028-8 | Patient health questionnaire-somatic, anxiety, and depressive symptoms total score | COMPONENT | 1 |
| LP146029-6 | Patient Health Questionnaire | METHOD | 85 |
| LP14603-2 | Transfuse factor IX | COMPONENT | 1 |
| LP146030-4 | Patient health questionnaire 4 item total score | COMPONENT | 1 |
| LP146031-2 | Patient health questionnaire 15 item total score | COMPONENT | 1 |
| LP146032-0 | Generalized anxiety disorder 7 item total score | COMPONENT | 1 |
| LP14604-0 | Transfuse factor VIII | COMPONENT | 1 |
| LP146043-7 | Follitropin Ab | COMPONENT | |
| LP146045-2 | t(X;11)(q13.1;q23)(FOXO4,MLL) | COMPONENT | |
| LP146046-0 | t(1;11)(p32;q23)(EPS15,MLL) | COMPONENT | |
| LP146047-8 | t(3;5)(q25.1;q35.1)(MLF1,NPM1) | COMPONENT | |
| LP146048-6 | t(3;21)(q26;q22.3)(MECOM,RUNX1) | COMPONENT | |
| LP146049-4 | t(5;17)(q25.1;q21.1)(NPM1,RARA) | COMPONENT | |
| LP14605-7 | H | COMPONENT | |
| LP146050-2 | t(6;11)(q27;q23)(MLLT4,MLL) | COMPONENT | |
| LP146051-0 | t(9;9)(q34;q34)(NUP214,SET) | COMPONENT | |
| LP146052-8 | t(9;12)(q34.1;p13)(ABL1,ETV6) | COMPONENT | |
| LP146053-6 | t(11;17)(q23;q21)(MLL,MLLT6) | COMPONENT | |
| LP146054-4 | t(11;17)(q23;q21.1)(ZBTB16,RARA) | COMPONENT | |
| LP146055-1 | t(11;19)(q23;p13.1)(MLL,ELL) | COMPONENT | |
| LP146056-9 | t(12;22)(p13;q12.1)(ETV6,MN1) | COMPONENT | |
| LP146057-7 | t(16;21)(p11.2;q22.3)(FUS,ERG) | COMPONENT | |
| LP146058-5 | t(17;19)(q22;p13.3)(HLF,TCF3) | COMPONENT | |
| LP14606-5 | Transfuse immune serum globulin | COMPONENT | 1 |
| LP146061-9 | Inversions | CLASS | |
| LP146062-7 | inv(16)(p13.1;q22.1)(MYH11,CBFB) | COMPONENT | |
| LP14607-3 | Transfuse Pentaspan | COMPONENT | 1 |
| LP14608-1 | Transfuse plasma | COMPONENT | 1 |
| LP146081-7 | CLN3 gene exon 7+8 | COMPONENT | |
| LP146082-5 | Del(1)(p32p32)(STIL,TAL1) | COMPONENT | |
| LP146085-8 | Blastocystis hominis DNA | COMPONENT | 1 |
| LP146086-6 | Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA | COMPONENT | 1 |
| LP146087-4 | Dientamoeba fragilis DNA | COMPONENT | 1 |
| LP146088-2 | Plesiomonas shigelloides DNA | COMPONENT | 3 |
| LP146089-0 | Patient information panel | COMPONENT | 1 |
| LP14609-9 | Transfuse platelets | COMPONENT | 1 |
| LP146090-8 | End Stage Renal Disease | METHOD | 114 |